Plus Therapeutics Inc [NASDAQ: PSTV] slipped around 23449999.63 points on Friday, while shares priced at $23450000.0 at the close of the session, down -14.05%.
Plus Therapeutics Inc stock is now -80.79% down from its year-to-date (YTD) trading value. PSTV Stock saw the intraday high of $0.3433 and lowest of $0.2974 per share. The company’s 52-week high price is 2.31, which means current price is +92.84% above from all time high which was touched on 03/07/25.
Compared to the average trading volume of 23.45M shares, PSTV reached a trading volume of 23589316 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Plus Therapeutics Inc [PSTV]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PSTV shares is $9.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PSTV stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Plus Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 17, 2025. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on January 25, 2021, representing the official price target for Plus Therapeutics Inc stock. Previously, the target price had yet another raise to $6, while Maxim Group analysts kept a Buy rating on PSTV stock.
How has PSTV stock performed recently?
Plus Therapeutics Inc [PSTV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 62.42. With this latest performance, PSTV shares gained by 15.42% in over the last four-week period, additionally sinking by -70.55% over the last 6 months – not to mention a drop of -72.60% in the past year of trading.
Plus Therapeutics Inc [PSTV]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Plus Therapeutics Inc [PSTV] shares currently have an operating margin of -286.82% and a Gross Margin at 83.73%. Plus Therapeutics Inc’s Net Margin is presently recorded at -520.90%.
Return on Equity for this stock declined to -306.82%, with Return on Assets sitting at -306.82%.
Earnings analysis for Plus Therapeutics Inc [PSTV]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PSTV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Plus Therapeutics Inc go to 53.45%.
Insider trade positions for Plus Therapeutics Inc [PSTV]
There are presently around $2.50%, or 2.55% of PSTV stock, in the hands of institutional investors. The top three institutional holders of PSTV stocks are: AIGH CAPITAL MANAGEMENT LLC with ownership of 0.57 million shares, which is approximately 8.7478%. GEODE CAPITAL MANAGEMENT, LLC, holding 46648.0 shares of the stock with an approximate value of $$68572.0 in PSTV stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $$47835.0 in PSTV stock with ownership which is approximately 0.5006%.
